Abstract
The publication of the updated individual patient data meta-analysis of the larger randomised trials of intravenous rt-PA for acute ischaemic stroke has re-opened the debate about how the treatment should be used in routine practice, and what information can be expected to emerge in the next 2-3 years from the ongoing trials [the largest of which is the Third International Stroke Trial (IST-3)].
| Original language | English |
|---|---|
| Pages (from-to) | 381-382 |
| Number of pages | 2 |
| Journal | International Journal of Stroke |
| Volume | 5 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - Oct 2010 |